MUKESH RANGWANI: Open Payments
NPI 1912072646 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,733 in 117 payments from 18 companies in 2025. Trend: 2023 $14,844 · 2024 $9,115 · 2025 $2,733
Food & beverage: $2,653Education: $80
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 22 | $517 |
| Axsome Therapeutics, Inc. | 6 | $409 |
| Neurocrine BioSciences, Inc. | 21 | $375 |
| Alkermes, Inc. | 16 | $340 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $197 |
| Teva Pharmaceuticals USA, Inc. | 9 | $162 |
| Lilly USA, LLC | 1 | $122 |
| Janssen Pharmaceuticals, Inc | 6 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
Products named: COBENFY, Auvelity, INGREZZA, ARISTADA, CAPLYTA, REXULTI, ZEPBOUND, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
